Who Should Not Take Melatonin?

Melatonin is widely promoted as a natural sleep aid, and short-term use appears safe for most adults. But melatonin is a hormone—not a simple vitamin—and it's not appropriate for everyone. Between 2012 and 2021, pediatric melatonin ingestions increased 530%, and certain medical conditions and medications create significant safety concerns. This guide identifies who should avoid melatonin and why, based on research and clinical evidence.

Table of Contents

1. Medical Conditions That Contraindicate Melatonin
2. Major Drug Interactions to Know
3. Age and Demographic Restrictions
4. Circadian and Sleep-Related Nuances
5. Product Quality and Accidental Overdose Risk
6. Long-Term Safety Concerns and Emerging Evidence
7. BioAbsorb Melatonin — Premium Quality Assurance
8. Frequently Asked Questions
9. Conclusion

1. Medical Conditions That Contraindicate Melatonin

Certain medical conditions are incompatible with melatonin supplementation due to how the hormone interacts with disease pathology or immune function. The Merck Manual explicitly recommends against melatonin use in people with dementia, epilepsy, autoimmune diseases, and those trying to conceive. The reason is mechanistic, not precautionary.

Dementia: While melatonin is studied for evening restlessness in Alzheimer's, the American Academy of Sleep Medicine recommends against melatonin in dementia. Older adults metabolize melatonin slowly, causing daytime drowsiness, confusion, and falls—particularly dangerous in dementia.

Epilepsy and Seizure Disorders: Melatonin may increase seizure frequency in people with epilepsy, particularly in children with neurological disorders. The mechanism isn't fully understood, but case reports and mechanistic studies suggest melatonin can lower the seizure threshold. Anyone with a seizure disorder must avoid melatonin without neurologist approval.

Autoimmune Diseases: Melatonin stimulates immune pathways and may exacerbate autoimmune diseases like lupus and rheumatoid arthritis. Avoidance is the cautious approach without specialist guidance.

2. Major Drug Interactions to Know

Melatonin interacts with multiple medication classes, sometimes dangerously. Mayo Clinic documents interactions with blood pressure medications, CNS depressants, diabetes medications, contraceptive drugs, and medications metabolized by the CYP1A2 and CPY2C19 liver enzymes. The most critical are blood thinners.

Anticoagulants and Blood Thinners (Warfarin): This is the most serious interaction. Melatonin can increase the effects of warfarin, raising bleeding risk. The mechanism involves reduced clotting factors: a controlled study found that a single 3mg melatonin dose decreased plasma clotting factor VIII by 21% and fibrinogen by 15% compared to placebo. A case series of 10 patients on concurrent melatonin-warfarin therapy showed elevated INR (International Normalized Ratio) in all patients, with 6 classified as "possible" and 2 as "probable" drug interactions. For safety, anyone on warfarin should avoid melatonin unless their doctor approves and monitors INR levels closely.

Blood Pressure Medications: Melatonin may worsen blood pressure control in people taking antihypertensive medications. Additionally, melatonin may interfere with calcium-channel blockers like nifedipine, reducing their effectiveness. People on blood pressure medications should discuss melatonin with their doctor before use.

CNS Depressants and Sleep Medications: Combining melatonin with sedatives, tranquilizers, benzodiazepines, or other sleep medications can cause additive drowsiness. This raises the risk of daytime impairment, falls, and accidents. Combining should only occur under medical direction.

Diabetes Medications: Melatonin may affect blood sugar levels and interfere with glucose-lowering medications. The interaction is complex and timing-dependent. Some research suggests melatonin impairs glucose tolerance when taken with food, while other evidence suggests benefits. Anyone with diabetes or prediabetes should consult their doctor before melatonin use.

3. Age and Demographic Restrictions

Age dramatically affects melatonin safety. The most vulnerable populations are infants, young children, and women of reproductive age.

Infants and Young Children: The American Academy of Sleep Medicine recommends against melatonin in children under 2 years, where sleep issues are behavioral, not biological. For older children, melatonin should address only insomnia or circadian rhythm disorders under medical supervision, with thorough evaluation to rule out other causes first.

Accidental Ingestion Risk: From 2012 to 2021, melatonin ingestions in children increased 530%, totaling 260,435 reported cases, with 4,000+ requiring hospitalization and 2 deaths. Most ingestions were unintentional, involving children under age 5 who mistook gummies for candy. The AASM advises storing melatonin in child-resistant packaging and locked cabinets, treating it like any prescription medication.

Pregnant and Breastfeeding Women: Safety of melatonin during pregnancy and breastfeeding is unknown, and melatonin may affect fertility in women trying to conceive. Because melatonin crosses the placenta and passes into breast milk, avoidance is the cautious approach unless a doctor approves supplementation.

4. Circadian and Sleep-Related Nuances

Surprisingly, melatonin isn't appropriate for all sleep problems, even in healthy adults. Efficacy varies dramatically by sleep issue type.

Insomnia Without Circadian Dysfunction: The American Academy of Sleep Medicine notes insufficient evidence for melatonin in chronic insomnia. Cognitive behavioral therapy (CBT-I) is preferred first-line treatment.

Timing Sensitivity: Melatonin's effects on glucose depend on timing relative to food—elevated melatonin during meals decreases glucose tolerance and insulin secretion. Shift workers and late-night eaters are at higher metabolic risk.

Genetic Susceptibility: People carrying the G-allele of the MTNR1B melatonin receptor gene show 11.7% worsening of glucose tolerance when given melatonin, a 25.2% decrease in early insulin secretion, and 40% reduction in first-phase insulin response. These individuals may have increased type 2 diabetes risk from melatonin supplementation. Genetic testing isn't routine, but people with a strong family history of diabetes should discuss melatonin risk with their doctor.

5. Product Quality and Accidental Overdose Risk

One of the largest hidden risks with melatonin is product quality variability. Because melatonin is unregulated as a dietary supplement in the United States, contents vary wildly and dangerously.

Labeling Accuracy Crisis: A study of 31 melatonin supplements found content ranging from −83% to +478% of labeled amount. 88% of melatonin gummies were inaccurately labeled, meaning you cannot reliably know the true dose.

Contaminant Risk: Some melatonin supplements contain unlabeled serotonin and other pharmaceutically active contaminants. These can interact with medications and cause adverse effects independent of melatonin itself.

Why Quality Matters for Safety: If you take an "overdose" of an unlabeled supplement—a person who unknowingly consumes 4 mg when the label says 1 mg—side effects escalate. Symptoms can include severe headaches, nausea, dizziness, and extreme next-day drowsiness. Quality manufacturers like BioAbsorb use third-party testing and GMP certification to verify exact melatonin content and absence of contaminants, reducing overdose and adverse effect risk significantly.

6. Long-Term Safety Concerns and Emerging Evidence

While short-term melatonin use (up to 3 months) is generally considered safe, long-term effects remain poorly understood—and emerging data raises concerns.

Cardiovascular Safety Questions: A preliminary American Heart Association analysis of 130,828 adults on melatonin ≥1 year found associations with increased heart failure risk and mortality, though causation cannot be proven. This warrants caution for long-term use.

Unknown Long-Term Effects in Children: Pediatricians express concern that long-term melatonin effects on growth, puberty, and hormonal development are unknown, and regular use in children should be avoided pending further research. Melatonin influences reproductive hormones; chronic supplementation might affect fertility or pubertal timing, but we lack long-term data.

Tolerance and Dependency: Some users report melatonin effectiveness decreases with nightly use. Whether stopping leads to worse insomnia isn't well-studied. Use melatonin only for short-term acute sleep issues, not chronic daily use.

7. BioAbsorb Melatonin — Premium Quality Assurance

For people for whom melatonin is appropriate, product quality is the first safety barrier. BioAbsorb Nutraceuticals manufactures premium melatonin with third-party testing, GMP certification, and rigorous quality control—verifying exact content and absence of contaminants. This eliminates the overdose and contamination risks inherent in unregulated supplements.

BioAbsorb's liposomal melatonin formulation achieves 80–95% bioavailability compared to 15–20% for standard tablets, meaning more of each dose is absorbed and utilized by your body. This precision reduces the need for high doses and improves consistency. Available in 1mg, 3mg, and 5mg formulations with precise graduated droppers, BioAbsorb allows fine-tuned dosing—critical for safe supplementation.

Even with a quality product, remember: melatonin is a hormone, not a sleeping pill. It should never replace medical evaluation for sleep problems. If you're considering melatonin, work with a healthcare provider to ensure it's appropriate for your health status, medications, and condition.

Frequently Asked Questions

Can I take melatonin if I'm on antidepressants?

It depends on the specific antidepressant. Melatonin can interact with SSRIs and other CNS-active medications, increasing drowsiness and potentially affecting serotonin levels. Discuss melatonin with your prescribing doctor before starting, especially if you're on fluvoxamine or other serotonergic drugs.

Is melatonin safe for people with bipolar disorder?

Melatonin may trigger mood episodes or interact with mood stabilizer medications. Anyone with bipolar disorder should not use melatonin without explicit psychiatric guidance.

What if my child accidentally swallows a handful of melatonin gummies?

Most pediatric melatonin overdoses are asymptomatic or cause mild drowsiness. However, some children require hospitalization for overdose symptoms including severe headache, dizziness, nausea, and extreme lethargy. Call Poison Control immediately: 1-800-222-1222. Keep melatonin in locked storage, never accessible to children.

I have a family history of diabetes. Should I avoid melatonin?

If you carry the MTNR1B G-allele genetic variant, melatonin worsens glucose tolerance and impairs insulin secretion. Talk to your doctor about whether melatonin is appropriate given your diabetes risk. Genetic testing is not routine, but your family history should prompt caution.

Can I use melatonin long-term for chronic insomnia?

Emerging evidence linking long-term melatonin use to increased cardiovascular risk warrants caution. Melatonin is best used for short-term, acute sleep issues. Chronic insomnia should be addressed with CBT-I, good sleep hygiene, and medical evaluation for underlying causes.

Conclusion

Melatonin is not the "natural, risk-free" sleep solution marketing often portrays. People with epilepsy, dementia, autoimmune diseases, those taking blood thinners or certain other medications, infants, young children, and pregnant women should avoid melatonin entirely. Even healthy adults should use melatonin only for short-term sleep issues after medical evaluation, preferably with a quality, third-party tested product. If melatonin is appropriate for you, BioAbsorb's third-party tested liposomal formulation removes quality and contamination concerns, allowing you to use melatonin safely with confidence in your dose. Your health is worth the care of understanding when melatonin helps and when it harms.

Research References

1. Melatonin — Mayo Clinic Drug Information. Mayo Clinic. Retrieved from https://www.mayoclinic.org/drugs-supplements-melatonin/art-20363071. Comprehensive clinical reference documenting major drug interactions with blood pressure medications, CNS depressants, diabetes medications, and CYP enzyme substrates.
2. Melatonin: What You Need To Know. National Center for Complementary and Integrative Health (NIH). Retrieved from https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know. Official US government guidance on melatonin safety, contraindications, and medical supervision requirements for specific populations.
3. Melatonin — Merck Manual Consumer Version. Merck & Co., Inc. Retrieved from https://www.merckmanuals.com/home/special-subjects/dietary-supplements-and-vitamins/melatonin. Professional medical reference identifying absolute contraindications in dementia, epilepsy, autoimmune disease, and warfarin use.
4. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. PMC/NIH. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9842516/. Peer-reviewed analysis of melatonin supplement quality control issues, documenting content variability from −83% to +478% of labeled dose and contaminant risks.
5. Pediatric Melatonin Ingestions — United States, 2012–2021. Centers for Disease Control and Prevention (CDC). MMWR, Vol. 71 (2022). Retrieved from https://www.cdc.gov/mmwr/volumes/71/wr/mm7122a1.htm. Official CDC epidemiological surveillance data on 260,435 pediatric melatonin ingestions, 530% increase, hospitalizations, and 2 deaths.
6. Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy young men. Wirtz, P.H., Spillmann, M., Bärtschi, C., Ehlert, U., & von Känel, R. Journal of Pineal Research, Vol. 44 (2008). Controlled randomized study demonstrating that 3mg melatonin decreased factor VIII by 21% and fibrinogen by 15%, showing dose-response relationship with bleeding risk.
7. Evaluation of the Potential Drug Interaction of Melatonin and Warfarin: A Case Series. Ashy, N., & Shroff, K. Life Science Journal, Vol. 13, No. 6 (2016). Retrieved from https://www.lifesciencesite.com/lsj/life130616/06_30694lsj130616_46_51.pdf. Clinical case series of 10 patients documenting elevated INR and PT with concurrent melatonin-warfarin use, requiring monitoring.
8. Health Advisory: Melatonin Use in Children and Adolescents. American Academy of Sleep Medicine (AASM). 2022. Retrieved from https://aasm.org/advocacy/position-statements/melatonin-use-in-children-and-adolescents-health-advisory/. Official professional organization guidance on melatonin safety in pediatric populations, labeling variability, and safe storage.
9. Melatonin use in typically developing children: International Pediatric Sleep Association (IPSA) Expert Consensus Recommendations for Healthcare Providers. Sleep Medicine Reviews, 2025. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S1389945725000474. Evidence-based expert consensus statement establishing age restrictions, indications, and clinical evaluation requirements for pediatric melatonin use.
10. Melatonin Effects on Glucose Metabolism: Time to Unlock the Controversy. PMC/NIH. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7349733/. Comprehensive review synthesizing conflicting literature on melatonin's timing-dependent effects on glucose tolerance, insulin secretion, and MTNR1B genetic variants.
11. Effects of Melatonin on Glucose, Insulin, and C-Peptide Dynamics in Carriers of MTNR1B Type 2 Diabetes Risk Variant. Sleep, Vol. 47, Supplement 1 (2024). Retrieved from https://academic.oup.com/sleep/article/47/Supplement_1/A381/7655307. Peer-reviewed controlled crossover trial documenting 11.7% worsening of glucose tolerance and 40% reduction in insulin secretion in MTNR1B risk carriers given melatonin.
12. Long-term use of melatonin supplements to support sleep may have negative health effects. American Heart Association. 2023. Retrieved from https://newsroom.heart.org/news/long-term-use-of-melatonin-supplements-to-support-sleep-may-have-negative-health-effects. Large observational analysis of 130,828 adults with insomnia on long-term melatonin, raising cardiovascular safety concerns requiring further investigation.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.